Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The aim of the project is to compare the nephro-protective effects of high-dose atorvastatin
and high-dose rosuvastatin on the incidence of Contrast Induced-Acute Kidney Injury in
patients with non-ST-elevation acute coronary syndromes scheduled for early invasive
strategy.